Emergency Procedural Sedation With XXXX in Older Teenagers: Any Cause for Concern?

@entity1 @entity341 @entity519 @entity1875 @entity551
INTRODUCTION: @entity1875 is a standard for adult @entity341 ( @entity341 ). Use in pediatric @entity1 remains controversial. Our primary objective was to investigate whether adverse events occurred more frequently in teenage pediatric @entity1 receiving @entity1875 for @entity341 . METHODS: This retrospective study examines records from the Halifax Procedural Sedation Registry, collected between January 1, 2006 and May 31, 2013. @entity1 undergoing @entity341 using @entity1875 were divided into those aged 16 to 19 years (teenagers), 20 to 65 years (adults), and older than 65 years (seniors). The primary outcomes were the incidences of @entity551 and @entity519 . RESULTS: Four thousand sixty-three EDPSs were included in the analysis, of which 230 involved teenagers, 2853 adults (mean age, 43.0 years), and 980 seniors (mean age, 77.1). The teenage group was significantly less likely to develop @entity551 or @entity519 . These differences were confirmed on multivariate analysis. @entity1 in the teenage group received higher doses of @entity1875 per kilogram/minute than the other groups. No other differences met statistical significance. CONCLUSIONS: Teenage @entity1 receiving @entity341 with @entity1875 had a lower incidence of adverse events, and both received and tolerated larger adjusted doses of medication than older @entity1 . Satisfaction and duration of @entity341 were similar. Concerns about @entity1875 use in younger @entity1 have not been supported by this study. We believe that these findings support the use of @entity1875 for @entity341 in older teenagers.
